Inventor · disambiguated record
Casi M. Schienebeck
Also filed as: SCHIENEBECK CASI · SCHIENEBECK CASI M
5 granted patents·4 pending applications·1 citations·filing 2021–2025
62Inventor score
Files withARROWHEAD PHARMACEUTICALS INC9
Top patents by PatentIndex Score
9 records- 0186US11845937B2RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2023·Granted Dec 19, 2023·1 cites·22 claims
- 0279US12378558B2RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2024·Granted Aug 5, 2025·0 cites·19 claims
- 0375US2025034577A1RNAi Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0469US2024392292A1RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0566US12054718B2RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Aug 6, 2024·0 cites·34 claims
- 0660US12365897B2RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Jul 22, 2025·0 cites·18 claims
- 0760US2023013022A1RNAi Agents for Inhibiting Expression of Beta-ENaC, Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0859US2025376688A1RNAi Agents for Inhibiting Expression of Proprotein Convertase Subtilisin Kexin 9 (PCSK9), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0956US12486502B2RNAi agents for inhibiting expression of receptor for advanced glycation end-products, compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Dec 2, 2025·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Casi M. Schienebeck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →